Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review)

Author：

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.45, Iss.3, 2014-01, pp. : 909-918

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Notch signaling in T-cell acute lymphoblastic leukemia

By Weng Andrew P Lau Arthur

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 511-519

Future Medicine

Access to resources Recommend Favorite

Targeting mTOR: Evaluating the Therapeutic Potential of Resveratrol for Cancer Treatment

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 1032-1038

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1457-1464

Spandidos Publications

Access to resources Recommend Favorite

Primary laryngeal manifestation in precursor T-cell acute lymphoblastic leukemia

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 691-694

Spandidos Publications

Access to resources Recommend Favorite

Genetic heterogeneity of RPMI-8402, a T-acute lymphoblastic leukemia cell line

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 593-599

Spandidos Publications

Access to resources Recommend Favorite